IFNG and autoimmune uveitis: In this study we show that the selective blockade of CD28 using a monovalent Fab fragment is effective in the treatment of experimental autoimmune uveitis acting directly on effector T cells, specifically dampening IFN-γ production with no induction of anergy or enhancement of Treg cell activity.